Healthcare -
Biotechnology - NASDAQ - US
$ 54.8
-1.03 %
$ 6.97 B
Market Cap
18.15
P/E
HALO - TOTAL OTHER INCOME
Total Other Income HALO - Halozyme Therapeutics, Inc.
10.8 M
LAST VALUE
54.69%
2 YEAR CAGR
24.80%
5 YEAR CAGR
18.66%
10 YEAR CAGR